The latest GPUs need a type of rare earth metal called Neodymium and there are only 29 companies in the world exploring or producing it. Find the list for free.
To own Align today, you need to believe that digital orthodontics and integrated workflows can still gain traction even with weaker case starts and pricing pressure. The latest AI upgrades look supportive of the near term catalyst of improving scanner and software utilization, but they do not remove the key risk that macro uncertainty and a shift back to metal braces could keep aligner volumes under pressure.
Among the new tools, the AI powered Align X ray Insights and broader oral health suite stand out as most relevant. They tie diagnostics, treatment planning, and patient communication more tightly into Align’s platform, which could matter for both the volume catalyst and the risk that pricing discounts and lower cost competitors chip away at margins if dentists do not fully adopt these integrated workflows.
But even with these AI tools, investors should be aware that...
Read the full narrative on Align Technology (it's free!)
Align Technology's narrative projects $4.7 billion revenue and $721.2 million earnings by 2029.
Uncover how Align Technology's forecasts yield a $209.07 fair value, a 24% upside to its current price.
While the baseline view focuses on modest 3 percent to 4 percent annual revenue growth, the most optimistic analysts were already modeling about US$5.0 billion of sales and roughly US$811.6 million of earnings by 2029, so these new AI tools could either bolster that upbeat mix shift story or underline how much opinions can differ on Align’s long term trajectory.
Explore 6 other fair value estimates on Align Technology - why the stock might be worth as much as 78% more than the current price!
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
Every day counts. These free picks are already gaining attention. See them before the crowd does:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com